Adamas Pharmaceuticals, Inc.

Q1 2019 13F Holders

Symbol
ADMS
CUSIP
00548A106
Type
Equity
Class
COM
Num filings
103
Total reported value, excl. options
$150 M
Manager Report Date Value ($000) Shares Option Type